What is he best known for?
The fields of study he is best known for:
Q. Ping Dou mostly deals with Biochemistry, Proteasome, Proteasome inhibitor, Cancer cell and Pharmacology.
He has included themes like Cancer research, In vitro, Ubiquitin and Apoptosis, Programmed cell death in his Proteasome study.
His biological study spans a wide range of topics, including Internal medicine, K562 cells, Cisplatin and Endocrinology.
His Proteasome inhibitor research incorporates elements of Cancer treatment and Biological activity.
His research on Cancer cell concerns the broader Cancer.
His Pharmacology research integrates issues from Carfilzomib, Multiple myeloma, Bortezomib, Gambogic acid and Leukemia.
His most cited work include:
- Novel metals and metal complexes as platforms for cancer therapy. (269 citations)
- Broad targeting of resistance to apoptosis in cancer. (252 citations)
- Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. (251 citations)
What are the main themes of his work throughout his whole career to date?
Q. Ping Dou mainly focuses on Proteasome, Cancer research, Apoptosis, Biochemistry and Proteasome inhibitor.
Q. Ping Dou combines subjects such as In vitro, Ubiquitin, Cancer cell, Bortezomib and Pharmacology with his study of Proteasome.
Q. Ping Dou interconnects Viability assay, AMPK and Cell biology in the investigation of issues within Cancer cell.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Internal medicine, Breast cancer, Prostate cancer and Cisplatin.
The Apoptosis study combines topics in areas such as Cell, Jurkat cells and Cell growth.
Biochemistry and Molecular biology are commonly linked in his work.
He most often published in these fields:
- Proteasome (51.81%)
- Cancer research (39.90%)
- Apoptosis (33.68%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (39.90%)
- Proteasome (51.81%)
- Cancer cell (26.94%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cancer research, Proteasome, Cancer cell, Ubiquitin and Bortezomib.
His research in Cancer research intersects with topics in Cancer, Breast cancer, Cisplatin, Cell growth and Small molecule.
Proteasome is a subfield of Biochemistry that Q. Ping Dou investigates.
His Cancer cell study integrates concerns from other disciplines, such as Apoptosis, Programmed cell death, DNA damage and Stereochemistry.
In his study, which falls under the umbrella issue of Ubiquitin, Autophagy, Nitric oxide synthase and Inflammation is strongly linked to Cell biology.
As part of the same scientific family, he usually focuses on Bortezomib, concentrating on Proteasome inhibitor and intersecting with Cadmium, Tryptophan and Schiff base.
Between 2016 and 2021, his most popular works were:
- Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination. (43 citations)
- Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination. (43 citations)
- Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing. (42 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Cancer research, Proteasome, Ubiquitin, Cancer cell and Apoptosis.
His Cancer research research is multidisciplinary, incorporating elements of Deubiquitinating enzyme, Breast cancer and Protein degradation.
Q. Ping Dou has researched Protein degradation in several fields, including Proteasome inhibitor, Carfilzomib, Bortezomib and Drug repositioning.
Cell biology covers Q. Ping Dou research in Proteasome.
His studies deal with areas such as Cell growth, Receptor and Androgen Receptor Positive, Androgen receptor, Prostate cancer as well as Cancer cell.
His Apoptosis research incorporates themes from Cancer, Ex vivo, Cytotoxic T cell, In vitro and Leukemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
